川大智胜(002253) - 2024 Q2 - 季度财报

Financial Performance - The company's operating revenue for the first half of 2024 was ¥87,074,532.15, representing a 9.33% increase compared to ¥79,643,223.95 in the same period last year[10]. - The net profit attributable to shareholders was -¥17,087,855.17, a decrease of 46.11% from -¥11,695,132.33 year-on-year[11]. - The net cash flow from operating activities was -¥8,359,193.96, a significant decline of 170.30% compared to ¥11,890,260.49 in the previous year[11]. - The company reported a basic earnings per share of -¥0.08, down 60.00% from -¥0.05 in the same period last year[11]. - Total assets at the end of the reporting period were ¥1,532,604,211.25, a decrease of 2.07% from ¥1,565,021,802.17 at the end of the previous year[11]. - The net loss attributable to shareholders was CNY 17.09 million, an increase in loss of 46.11% year-on-year, primarily due to increased management expenses, R&D expenses, and credit impairment losses[16]. - Operating cash flow net amount was CNY -8.36 million, a decrease of 170.30% year-on-year, mainly due to a reduction in sales collections by CNY 14.46 million[19]. - The company reported a significant increase in travel expenses by 72.35% year-on-year, amounting to CNY 1.87 million[21]. - The net increase in cash and cash equivalents was CNY -13.25 million, a decline of 588.59% compared to the previous year[19]. - The company reported a total comprehensive income loss of CNY 15,235,742.48 for the first half of 2024, indicating a significant decline in profitability[68]. Research and Development - R&D expenses amounted to CNY 18.09 million, representing a year-on-year increase of 7.26%[19]. - Research and development expenses rose to RMB 18,090,626.86, an increase of 7.26% from RMB 16,865,449.09 in the previous year[53]. - Research and development expenses have increased by 25%, totaling 150 million yuan, focusing on innovative software solutions[117]. Assets and Liabilities - The company's total assets decreased to RMB 1,396,498,423.78 from RMB 1,432,652,249.54, reflecting a decline of 2.51%[52]. - Total liabilities decreased to RMB 210,488,017.30, down 9.05% from RMB 231,406,100.58 year-on-year[52]. - The company's total equity at the end of the first half of 2024 was 1,222,846,839.59 RMB, compared to 1,240,779,651.80 RMB at the end of the previous year, showing a decrease of approximately 1.4%[64]. - The company's equity attributable to shareholders decreased to RMB 1,186,525,630.38 from RMB 1,203,613,485.55, reflecting a decrease of approximately 1.4%[49]. Cash Flow - The company reported a net cash outflow from operating activities of ¥8,359,193.96, a significant decline from a net inflow of ¥11,890,260.49 in the first half of 2023[59]. - The cash outflow for employee compensation increased to 19,504,112.49 RMB in the first half of 2024, up from 13,788,480.23 RMB in the same period of 2023, reflecting higher personnel costs[62]. - The company's cash flow from operations improved by 30%, reaching 400 million yuan, indicating strong financial health[121]. Shareholder Information - The total number of shares before the change was 225,626,095, with 8.18% being restricted shares and 91.82% being unrestricted shares[38]. - The total number of shareholders at the end of the reporting period was 49,636[39]. - The largest shareholder, You Zhisheng, holds 9.13% of the shares, totaling 20,589,033 shares[39]. - The company has no preferred shares outstanding during the reporting period[45]. Corporate Governance - The company plans not to distribute cash dividends or issue bonus shares for the semi-annual period[30]. - There were no equity incentive plans or employee stock ownership plans implemented during the reporting period[30]. - The company maintains a good integrity status with no unfulfilled court judgments or significant debts due[35]. - The company has committed to timely and accurate disclosure of significant information affecting investors[33]. Market and Product Development - The company has completed the prototype production of a new device for "psychological health status multimodal non-contact automatic detection and screening," based on its high-speed three-dimensional micro-expression capture camera[15]. - The company is classified as a national high-tech enterprise, focusing on air traffic management and artificial intelligence[76]. - The company’s main business includes software development and artificial intelligence public service platform technology consulting[77]. - The company is exploring potential acquisitions to enhance its technology portfolio, with a budget of 500 million yuan allocated for this purpose[118]. Accounting and Financial Reporting - The financial statements are prepared in accordance with the Chinese Accounting Standards, reflecting the company's financial position, operating results, and cash flows accurately[85]. - The company recognizes lease liabilities at the present value of unpaid lease payments, excluding short-term and low-value asset leases[191]. - The company has implemented changes in accounting policies effective from January 1, 2024, in accordance with the Ministry of Finance's guidelines, which will not significantly impact its financial status or results[191]. Legal and Compliance - The company had 5 lawsuits as a plaintiff with a total amount involved of 21.49 million yuan, and 4 lawsuits as a defendant with an amount of 1.07 million yuan[34]. - The company had no significant related party transactions involving asset or equity acquisitions or sales during the reporting period[36]. - The company had no major guarantees or entrusted financial management during the reporting period[37].